| Institution: | Division of Molecular Psychiatry, Departments of Psychiatry and Pharmacology, Yale University School of Medicine, New Haven, Connecticut;; Division of Neuroscience, Oregon Regional Primate Research Center, Beaverton;; Graduate Programs in Neuroscience and Molecular and Cell Biology, Oregon Health Sciences University, Portland, Oregon;and; Membrane Biochemistry Section, Laboratory of Molecular and Cellular Neurobiology, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, U.S.A. |
